Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine

International Journal of Cancer

Volumn 95, Issue 6, 2001, Pages 364-369

  Seripa, Davide ^a   Parrella, Paola ^b,c   Gallucci, Michele ^b,d   Gravina, Carolina ^a   Papa, Sara ^a   Fortunato, Pasquale ^d   Alcini, Antonio ^b   Flammia, Gerardo ^b   Lazzari, Marzia ^e   Fazio, Vito M ^a,b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Cristo Re Hospital   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Diagnosis; Genomic instability; Prognosis; Tumor progression

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER IRRIGATION; BLADDER MUCOSA; CANCER CELL; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SILVER STAINING; TRINUCLEOTIDE REPEAT EXPANSION; URINARY BLADDER NEOPLASMS;

EID: 0035923276     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20011120)95:6<364::AID-IJC1064>3.0.CO;2-V     Document Type: Article

References (56)

1. Global cancer statistics
2. Cancer statistics, 2000
3. Prognostic markers in bladder cancer: A contemporary review of the literature
4. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract
5. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms
6. Diagnosis and staging of bladder cancer
7. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa
8. Office evaluation and management of bladder neoplasms
9. A genetic model for colorectal tumorigenesis
10. Allelotype of colorectal carcinomas
11. Allelotype analysis of early colorectal cancers with lymph node metastasis
12. Allelotype profiles of local recurrences and distant metastases from colorectal-cancer patients
13. Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast
14. Microsatellite instability is correlated with lymph node-positive breast cancer
15. Microsatellite instability in ductal carcinoma in situ of the breast
16. Allelotype of non-small cell lung carcinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma
17. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung
18. Comparative allelotype of early and advanced stage non-small cell lung carcinomas
19. Allelotype of head and neck squamous cell carcinoma
20. Allelotype of renal cell carcinoma
21. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi
22. Allelotype of posterior uveal melanoma: Implications for a bifurcated tumor progression pathway
23. Nucleic acid-based methods for the detection of cancer
24. Clonal origin of bladder cancer
25. Initiation of bladder cancer may involve deletion of a tumor-suppressor gene on chromosome 9
26. Role of chromosome 9 in human bladder cancer
27. Evidence for two bladder cancer suppressor loci on human chromosome 9
28. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder
29. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors
30. Loss of genes on the short arm of chromosome 11 in bladder cancer
31. Deletion mapping of chromosome 11 in carcinoma of the bladder
32. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder
33. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma
34. Accumulated allelic losses in the development of invasive urothelial cancer
35. Molecular genetic alterations in superficial and locally advanced human bladder cancer
36. Allelic losses of chromosome 9, 11 and 17 in human bladder cancer
37. Allelotype of human bladder cancer
38. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms
39. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma
40. Microsatellite alterations in plasma DNA of small cell lung cancer patients
41. Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients
42. Microsatellite alterations in serum DNA of head and neck cancer patients
43. Molecular detection of genetic alterations in the serum of colorectal cancer patients
44. Molecular detection of primary bladder cancer by microsatellite analysis
45. Detection of bladder cancer recurrence by microsatellite analysis of urine
46. Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder
47. Shadow bands seen when typing polymorphic dinucleotide repeats: Some causes and cures
48. Current status of urinary cytology in the evaluation of bladder neoplasms
49. Diagnostic value of cytology of voided urine
50. Grading of transitional cell neoplasms of the urinary bladder from smears of bladder washings. A critical review of 326 tumors
51. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer